Literature DB >> 21073236

Cell-penetrating peptides, electroporation and drug delivery.

K Cahill1.   

Abstract

Certain short polycations, such as trans-activating transcriptional activator and oligoarginine, rapidly pass through the plasma membranes of mammalian cells by a mechanism called transduction, as well as by endocytosis and macropinocytosis. These cell-penetrating peptides can carry with them cargos of 30 amino acids, more than the nominal limit of 500 Da and enough to be therapeutic. An analysis of the electrostatics of a charge outside the cell membrane and some recent experiments suggest that transduction may proceed by molecular electroporation. Ways to target diseased cells, rather than all cells, are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073236     DOI: 10.1049/iet-syb.2010.0007

Source DB:  PubMed          Journal:  IET Syst Biol        ISSN: 1751-8849            Impact factor:   1.615


  4 in total

Review 1.  Delivery of intracellular-acting biologics in pro-apoptotic therapies.

Authors:  Hongmei Li; Chris E Nelson; Brian C Evans; Craig L Duvall
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

2.  Involvement of a Rac1-Dependent Macropinocytosis Pathway in Plasmid DNA Delivery by Electrotransfection.

Authors:  Mao Mao; Liangli Wang; Chun-Chi Chang; Katheryn E Rothenberg; Jianyong Huang; Yingxiao Wang; Brenton D Hoffman; Paloma B Liton; Fan Yuan
Journal:  Mol Ther       Date:  2017-01-24       Impact factor: 11.454

3.  Endosomolytic Nano-Polyplex Platform Technology for Cytosolic Peptide Delivery To Inhibit Pathological Vasoconstriction.

Authors:  Brian C Evans; Kyle M Hocking; Kameron V Kilchrist; Eric S Wise; Colleen M Brophy; Craig L Duvall
Journal:  ACS Nano       Date:  2015-06-02       Impact factor: 15.881

4.  Efficient prediction of drug-drug interaction using deep learning models.

Authors:  Prashant Kumar Shukla; Piyush Kumar Shukla; Poonam Sharma; Paresh Rawat; Jashwant Samar; Rahul Moriwal; Manjit Kaur
Journal:  IET Syst Biol       Date:  2020-08       Impact factor: 1.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.